Announcements Trials
Browse Landscape

Phase

Phase 2 47Phase 1 20Phase 3 13Phase 1/2 11Phase NA 2Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 15Thoracic 8Genitourinary 7Gastrointestinal 5Head & Neck 3Gynecologic 2Tumor-Agnostic 1

Conditions

Uterine Neoplasms 1Stomach Neoplasms 1Peritoneal Neoplasms 1

Interventions

Blood Specimen Collection 34Methods 25Early Intervention, Educational 24Standard of Care 21Colposcopy 21Surveys and Questionnaires 19Educational Status 18Sentinel Lymph Node Biopsy 17Cisplatin 17Counseling 16Brachytherapy 16Exercise 15Interviews as Topic 13Carboplatin 13Therapeutics 12Surgical Procedures, Operative 11Paclitaxel 11Magnetic Resonance Spectroscopy 11Indocyanine Green 11Biopsy 11Radiotherapy 10Practice Guidelines as Topic 10Palliative Care 10Human Papillomavirus DNA Tests 10Behavior Therapy 10Specimen Handling 9Radiotherapy, Intensity-Modulated 9Psychiatric Rehabilitation 9Lymph Node Excision 9Genetic Testing 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Docetaxel × Gynecologic × Clear all
NCT04595929 2020-11-25

GASPACCO

St. Petersburg State Pavlov Medical University

Phase NA Recruiting
304 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT00614835 2015-12-22

Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

Memorial Sloan Kettering Cancer Center

Phase NA Completed
25 enrolled
Gynecologic

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡